Key Highlights
- Kevin Smith Appointed as President and CEO: Bringing over 20 years of experience in the medical device industry, Smith takes the helm at Inogen, succeeding Nabil Shabshab.
- Strategic Focus on Growth and Efficiency: Smith’s appointment is part of Inogen’s strategy to scale business, improve operational efficiencies, and accelerate growth.
- Extensive Leadership Background: Smith’s prior roles include CEO of Sirtex Medical Limited and senior positions at Sensium Healthcare Ltd., Teleflex, Hillrom Holdings, and ZOLL Medical Corporation.
Source: Business Wire
Notable Quotes
- “We believe Kevin is the right leader to capitalize on Inogen’s potential… look forward to benefitting from his expertise as we seek to advance our commercial strategy, win new customers, and drive sustainable, long-term value for our shareholders.” – Elizabeth Mora, Chairperson of the Board at Inogen
- “I am honored to join Inogen, a company with a strong brand, global reach, and purpose-led vision… I look forward to working with the Board and entire team to drive growth, innovation, and enhanced performance to create value for patients and our shareholders alike.” – Kevin Smith, President and Chief Executive Officer at Inogen
SoH's Take
The appointment of Kevin Smith as President and CEO of Inogen marks a significant moment in the company’s trajectory. Smith’s extensive experience in the medical device sector, particularly in respiratory care, aligns well with Inogen’s core business and strategic goals. His proven track record in leading companies through growth phases and expanding global markets is a strong indicator of potential success in his new role. Inogen’s focus on operational efficiency and market expansion under Smith’s leadership could further solidify its position as a leader in portable oxygen therapy solutions. This change at the top also signifies Inogen’s readiness to adapt and evolve in a dynamic healthcare market, potentially ushering in a new era of innovation and customer-focused growth.
